Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2002
Published online before print October 3, 2002, doi: 10.1161/01.RES.0000039530.30495.6F
A more recent version of this article appeared on November 1, 2002
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
91/9/830    most recent
01.RES.0000039530.30495.6Fv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Machado, J. D.
Right arrow Articles by Borges, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Machado, J. D.
Right arrow Articles by Borges, R.
Related Collections
Right arrow Cardiovascular Pharmacology
Right arrow Cell biology/structural biology
Right arrow Cell signalling/signal transduction
Right arrow Hypertension - basic studies

Submitted on January 14, 2002
Revised on September 13, 2002
Accepted on September 19, 2002

Hydralazine Reduces the Quantal Size of Secretory Events by Displacement of Catecholamines From Adrenomedullary Chromaffin Secretory Vesicles

José D. Machado ; José F. Gómez ; Gema Betancor ; Marcial Camacho ; Miguel A. Brioso ; and Ricardo Borges *

From the Unidad de Farmacología, Facultad de Medicina, Universidad de La Laguna, Tenerife, Spain.

* To whom correspondence should be addressed. E-mail: rborges{at}ull.es.

The effects of the antihypertensive agent hydralazine (1 to 100 nmol/L) on the exocytotic process of single adrenal chromaffin cells have been studied using amperometry. Hydralazine does not reduce the frequency of exocytotic spikes but rapidly slows the rate of catecholamine release from individual exocytotic events by reducing the quantal size of catecholamine exocytosis. Confocal and standard epifluorescence microscopy studies show that hydralazine rapidly accumulates within secretory vesicles. The blockade of the vesicular H+ pump with bafilomycin A1 inhibits hydralazine uptake. Experiments with permeabilized cells show that hydralazine displaces catecholamines from secretory vesicles. The drug also displaces vesicular Ca2+, as shown by fura-2 microfluorimetry. These data suggest that hydralazine acts, at least partially, by interfering with the storage of catecholamines. These effects of hydralazine occurred within seconds, and at the tissue concentrations presumably reached in antihypertensive therapy; these concentrations are a thousand times lower than those described for relaxing vascular tissues in vitro. We proposed that these novel effects could explain many of the therapeutic and side effects of this drug that are likely exerted in sympathetic nerve terminals.


Key words: amperometry • bafilomycin A1 • catecholamines • chromaffin granules • intragranular pH




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
M. Camacho, J. D. Machado, J. Alvarez, and R. Borges
Intravesicular Calcium Release Mediates the Motion and Exocytosis of Secretory Organelles: A STUDY WITH ADRENAL CHROMAFFIN CELLS
J. Biol. Chem., August 15, 2008; 283(33): 22383 - 22389.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
A. G. Garcia, A. M. Garcia-De-Diego, L. Gandia, R. Borges, and J. Garcia-Sancho
Calcium signaling and exocytosis in adrenal chromaffin cells.
Physiol Rev, October 1, 2006; 86(4): 1093 - 1131.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. R. Mahapatra, M. Mahata, P. P. Hazra, P. M. McDonough, D. T. O'Connor, and S. K. Mahata
A Dynamic Pool of Calcium in Catecholamine Storage Vesicles: EXPLORATION IN LIVING CELLS BY A NOVEL VESICLE-TARGETED CHROMOGRANIN A-AEQUORIN CHIMERIC PHOTOPROTEIN
J. Biol. Chem., December 3, 2004; 279(49): 51107 - 51121.
[Abstract] [Full Text] [PDF]